Yale Jen
Stock Analyst at Laidlaw & Co.
(0.28)
# 4,370
Out of 5,093 analysts
14
Total ratings
14.29%
Success rate
-10.62%
Average return
Main Sectors:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FEMY Femasys | Initiates: Buy | $6.5 | $0.82 | +695.11% | 1 | Nov 20, 2025 | |
| NSRX Nasus Pharma | Initiates: Buy | $22 | $6.82 | +222.58% | 1 | Sep 29, 2025 | |
| SNTI Senti Biosciences | Initiates: Buy | $5 | $2.39 | +109.21% | 1 | Jun 6, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $51.18 | +105.16% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $6.65 | +185.71% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $10 | $0.69 | +1,347.18% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $115.05 | -58.28% | 1 | Jul 29, 2024 | |
| PHGE BiomX | Initiates: Buy | $475 | $3.26 | +14,470.55% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $225 | $1.78 | +12,540.45% | 1 | Mar 18, 2024 | |
| CING Cingulate | Downgrades: Hold | n/a | $3.92 | - | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.45 | +2,100.70% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.09 | - | 1 | Aug 15, 2023 |
Femasys
Nov 20, 2025
Initiates: Buy
Price Target: $6.5
Current: $0.82
Upside: +695.11%
Nasus Pharma
Sep 29, 2025
Initiates: Buy
Price Target: $22
Current: $6.82
Upside: +222.58%
Senti Biosciences
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $2.39
Upside: +109.21%
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $51.18
Upside: +105.16%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $6.65
Upside: +185.71%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $10
Current: $0.69
Upside: +1,347.18%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $115.05
Upside: -58.28%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $475
Current: $3.26
Upside: +14,470.55%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $1.78
Upside: +12,540.45%
Cingulate
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.92
Upside: -
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.45
Upside: +2,100.70%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.09
Upside: -